BackgroundTo study the effective therapeutic concentration, drug application duration,
irradiation duration and irradiation dosage of 5-aminolevulinic acid
photodynamic therapy (ALA-PDT) for treating vitiligo and observe its
clinical efficacy.ObjectiveTo assess the clinical efficacy of ALA-PDT for treating vitiligo.MethodsALA with different drug concentrations, drug application durations,
irradiation durations and irradiation dosages were adopted to treat skin
lesions caused by vitiligo to determine the effective drug concentration,
drug application duration, irradiation duration and irradiation dosage for
treating three vitiligo volunteers and observe the therapeutic results.ResultsThe clinical trial suggested that ALA at a drug concentration of 1.5%, drug
application duration for 3 hours, irradiation dosage of 80mw/cm2
and irradiation duration for 20 min was effective in treating vitiligo.
Under these parameters, ALA-PDT was effective to the three vitiligo
volunteers, with mild pain and feeling of burning but no other adverse
reaction during treatment.Study limitationsDue to the small sample size in this study for the effectiveness of PDT in
treating vitiligo and the potential variations in the efficacy for treating
the disease at different areas, further studies shall be conducted for
confirmation.ConclusionsALA with a drug concentration at 1.5%, drug application duration for 3 hours,
irradiation dosage of 80 mw/cm2 and irradiation duration for 20
min is effective in treating vitiligo. Therefore, ALA-PDT is safe and
effective in treating the disease, with minor adverse events, providing a
new method for treating vitiligo in the future.